Answers are grounded in this paper and cite their sources.
Allogeneic HSCT recipients have an increased risk of BCC, SCC, and MM. Total-body irradiation was a major determinant for BCC. Our findings indicate the relevance of dermatologic follow-up in HSCT recipients.
No takes yet. Share an insight, caveat, or question.
Omland et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: